NO20003273D0 - Substituerte <beta>-alaniner - Google Patents
Substituerte <beta>-alaninerInfo
- Publication number
- NO20003273D0 NO20003273D0 NO20003273A NO20003273A NO20003273D0 NO 20003273 D0 NO20003273 D0 NO 20003273D0 NO 20003273 A NO20003273 A NO 20003273A NO 20003273 A NO20003273 A NO 20003273A NO 20003273 D0 NO20003273 D0 NO 20003273D0
- Authority
- NO
- Norway
- Prior art keywords
- beta
- compounds
- prodrugs
- halogen
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Polyamides (AREA)
- Indole Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9727532.5A GB9727532D0 (en) | 1997-12-23 | 1997-12-23 | Chemical compounds |
US9260298P | 1998-07-13 | 1998-07-13 | |
PCT/GB1998/003859 WO1999033789A1 (en) | 1997-12-23 | 1998-12-23 | SUBSTITUTED β-ALANINES |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20003273D0 true NO20003273D0 (no) | 2000-06-22 |
NO20003273L NO20003273L (no) | 2000-06-22 |
Family
ID=26312873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20003273A NO20003273L (no) | 1997-12-23 | 2000-06-22 | Substituerte <beta>-alaniner |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1042279B1 (no) |
JP (1) | JP4555469B2 (no) |
KR (1) | KR20010033520A (no) |
CN (1) | CN1163477C (no) |
AT (1) | ATE289991T1 (no) |
AU (1) | AU747907B2 (no) |
BR (1) | BR9814376A (no) |
CA (1) | CA2316235A1 (no) |
CZ (1) | CZ20002342A3 (no) |
DE (1) | DE69829215T2 (no) |
ES (1) | ES2235383T3 (no) |
HK (1) | HK1034508A1 (no) |
HU (1) | HUP0101701A3 (no) |
IL (1) | IL136584A (no) |
NO (1) | NO20003273L (no) |
NZ (1) | NZ505363A (no) |
SK (1) | SK9372000A3 (no) |
TR (1) | TR200001947T2 (no) |
WO (1) | WO1999033789A1 (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1294576A (zh) * | 1998-01-23 | 2001-05-09 | 诺瓦提斯公司 | Vla-4拮抗剂 |
HUP0200481A3 (en) | 1998-12-23 | 2002-12-28 | Aventis Pharma Ltd West Mallin | Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines, process for their preparation and pharmaceutical compositions containing them |
TR200102399T2 (tr) * | 1999-02-18 | 2002-01-21 | F. Hoffmann-La Roch Ag | Tiyoamid türevleri |
KR20020067050A (ko) * | 1999-12-28 | 2002-08-21 | 화이자 프로덕츠 인코포레이티드 | 염증성, 자기면역 및 호흡기 질환의 치료에 유용한브이엘에이-4 의존성 세포 결합의 비펩티드계 억제제 |
DE10019755A1 (de) * | 2000-04-20 | 2001-11-08 | Bayer Ag | Neue Aminoaryl/cycloalkylcarbonsäuren als Integrinantagonisten |
FR2812633A1 (fr) * | 2000-08-04 | 2002-02-08 | Aventis Cropscience Sa | Derives de phenyl(thio)urees et phenyl(thio)carbamates fongicides |
GB2367816A (en) * | 2000-10-09 | 2002-04-17 | Bayer Ag | Urea- and thiourea-containing derivatives of beta-amino acids |
GB2369357A (en) * | 2000-10-09 | 2002-05-29 | Bayer Ag | Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
MXPA03003829A (es) | 2000-11-04 | 2003-07-28 | Aventis Pharma Ltd | Acidos alcanoicos substituidos. |
ATE524441T1 (de) | 2000-12-28 | 2011-09-15 | Daiichi Seiyaku Co | Vla-4-inhibitoren |
GB2377933A (en) | 2001-07-06 | 2003-01-29 | Bayer Ag | Succinic acid derivatives useful as integrin antagonists |
MXPA06000850A (es) | 2003-07-24 | 2006-03-30 | Daiichi Seiyaku Co | Compuesto de acido ciclohexancarboxilico. |
JP2008539246A (ja) * | 2005-04-28 | 2008-11-13 | フェリング ベスローテン フェンノートシャップ | Ibd治療のための新規化合物の使用 |
JP5107724B2 (ja) | 2005-12-13 | 2012-12-26 | 第一三共株式会社 | Vla−4阻害薬 |
EP2124996A4 (en) | 2007-02-20 | 2010-03-24 | Merrimack Pharmaceuticals Inc | METHODS OF TREATING MULTIPLE SCLEROSIS BY ADMINISTERING ALPHA-FETOPROTEIN COMBINED WITH INTEGRIN ANTAGONIST |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6306840B1 (en) * | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
KR100481285B1 (ko) * | 1995-08-30 | 2005-08-08 | 지.디. 썰 엘엘씨 | 인테그린길항제로서의메타-구아니딘,우레아,티오우레아또는아자고리아미노벤조산유도체 |
ES2162676T3 (es) * | 1996-03-29 | 2002-01-01 | Searle & Co | Derivados de fenileno sustituidos en meta y su uso como antagonistas o inhibidores de integrina alfav,beta3. |
ES2172780T3 (es) * | 1996-03-29 | 2002-10-01 | Searle & Co | Derivados de acido fenilpropanoico sustituidos en para como antagonistas de integrina. |
SK5462000A3 (en) * | 1997-10-31 | 2001-02-12 | Aventis Pharma Ltd | Substituted anilides |
-
1998
- 1998-12-23 HU HU0101701A patent/HUP0101701A3/hu unknown
- 1998-12-23 CA CA002316235A patent/CA2316235A1/en not_active Abandoned
- 1998-12-23 KR KR1020007007022A patent/KR20010033520A/ko not_active Application Discontinuation
- 1998-12-23 AT AT98962586T patent/ATE289991T1/de not_active IP Right Cessation
- 1998-12-23 JP JP2000526473A patent/JP4555469B2/ja not_active Expired - Lifetime
- 1998-12-23 EP EP98962586A patent/EP1042279B1/en not_active Expired - Lifetime
- 1998-12-23 DE DE69829215T patent/DE69829215T2/de not_active Expired - Lifetime
- 1998-12-23 BR BR9814376-0A patent/BR9814376A/pt not_active Application Discontinuation
- 1998-12-23 CN CNB988125005A patent/CN1163477C/zh not_active Expired - Fee Related
- 1998-12-23 CZ CZ20002342A patent/CZ20002342A3/cs unknown
- 1998-12-23 AU AU17719/99A patent/AU747907B2/en not_active Ceased
- 1998-12-23 SK SK937-2000A patent/SK9372000A3/sk unknown
- 1998-12-23 WO PCT/GB1998/003859 patent/WO1999033789A1/en active Search and Examination
- 1998-12-23 TR TR2000/01947T patent/TR200001947T2/xx unknown
- 1998-12-23 IL IL13658498A patent/IL136584A/xx not_active IP Right Cessation
- 1998-12-23 NZ NZ505363A patent/NZ505363A/en unknown
- 1998-12-23 ES ES98962586T patent/ES2235383T3/es not_active Expired - Lifetime
-
2000
- 2000-06-22 NO NO20003273A patent/NO20003273L/no not_active Application Discontinuation
-
2001
- 2001-07-27 HK HK01105254A patent/HK1034508A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2316235A1 (en) | 1999-07-08 |
ES2235383T3 (es) | 2005-07-01 |
AU1771999A (en) | 1999-07-19 |
SK9372000A3 (en) | 2002-03-05 |
BR9814376A (pt) | 2000-10-10 |
EP1042279A1 (en) | 2000-10-11 |
HUP0101701A2 (hu) | 2001-11-28 |
ATE289991T1 (de) | 2005-03-15 |
WO1999033789A1 (en) | 1999-07-08 |
NZ505363A (en) | 2005-02-25 |
JP2001527061A (ja) | 2001-12-25 |
HUP0101701A3 (en) | 2003-02-28 |
TR200001947T2 (tr) | 2001-01-22 |
KR20010033520A (ko) | 2001-04-25 |
HK1034508A1 (en) | 2001-10-26 |
DE69829215D1 (de) | 2005-04-07 |
CZ20002342A3 (cs) | 2001-11-14 |
NO20003273L (no) | 2000-06-22 |
IL136584A (en) | 2005-03-20 |
DE69829215T2 (de) | 2005-07-21 |
CN1163477C (zh) | 2004-08-25 |
EP1042279B1 (en) | 2005-03-02 |
AU747907B2 (en) | 2002-05-30 |
CN1283181A (zh) | 2001-02-07 |
IL136584A0 (en) | 2001-06-14 |
JP4555469B2 (ja) | 2010-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE289991T1 (de) | Substituierte beta-alaninen | |
DK1027328T3 (da) | Substituerede anilider | |
DE69523169D1 (de) | Verwendung von Mangiferin oder seinen Derivaten zur kosmetischen Anwendung | |
TR200102959T2 (tr) | İntegrin antagonistleri olarak ikame edilmiş bisiklik heteroaril bileşikleri | |
HUP0204496A2 (en) | Novel piperidine compounds and pharmaceutical compositions containing the same and process for preparation the same | |
SE9604786D0 (sv) | New compounds | |
IL151172A0 (en) | Amine derivatives, their preparation and use as bax modulators | |
ATE270668T1 (de) | Phenoxypropanolamin-derivate, ihre herstellung und therapeutische verwendung | |
HU9603185D0 (en) | New azolidinediones as antihyperglycemic agents | |
FR2712591B1 (fr) | Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique. | |
CO4820432A1 (es) | Composiciones farmaceuticas para el tratamiento de rinitis que comprenden acido 2-(4-(difenilmetil)-1-piperacinil)-ace- tico o amida derivada y un compuesto seleccionado de pseudoe fedrina,fenilpropanolamina y fenilefrina | |
NO944892L (no) | N-substituerte 3-azabicyklo (3.2.0) hepatanderivater som neuroleptika osv. | |
ATE126221T1 (de) | Thiazolidinverbindeungen, deren herstellung und therapeutische verwendung. | |
HUP0102025A2 (hu) | Diaril-1,3,4-oxadiazolon-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
DE69402935D1 (de) | Substituierte arylalkylaminobenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel | |
PT89082A (pt) | Processo para a preparacao de novos derivados n-(23-vinblastinoilicos)do acido 1-amino-metilfosfonico | |
PT1068184E (pt) | Derivados n-ariloxietilamina para o tratamento de depressao | |
EP0638564A4 (en) | BENZOTHIAZOLESULFONAMIDE DERIVATIVE, PROCESS FOR PRODUCING THE SAME AND APPLICATION THEREOF. | |
ATE245986T1 (de) | Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3- benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen | |
NO950177D0 (no) | Farmakologisk aktive erivater | |
MXPA02001861A (es) | Nuevos inhbidores de la integrina alfav beta3. | |
BR9507668A (pt) | Intermédio para preparar um composto farmaceuticamente atívo | |
EP1241166A4 (en) | 3-MEHTYL CHROMAN AND THIOCHROME DERIVATIVES | |
DE69400908D1 (de) | Verwendung von riluzol zum schutz gegen strahlenschäden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |